COMMUNIQUÉS West-GlobeNewswire

SPINEWAY : Assemblée Générale Mixte du 4 juin 2025 - Mise à disposition des documents préparatoires
19/05/2025
Communiqué de presse Ecully, le 19 mai 2025 – 18h30 SPINEWAY Assemblée Générale Mixte du 4 juin 2025 Mise à disposition des documents préparatoires Spineway informe ses actionnaires qu’ils sont invités à participer à l’ [...]
Spineway : Combined General Meeting of June 4, 2025 - Availability of preparatory documents
19/05/2025
Press release Ecully, May 19, 2025 – 6.30 p.m. SPINEWAY Combined General Meeting of June 4, 2025 Availability of preparatory documents Spineway informs its shareholders that they are invited to attend the Combined [...]
Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study
19/05/2025
- For each 5-mg/dL increase in serum TTR level within 28 days of starting treatment, the relative risk reduction of mortality was up to 31.6% through Month 30, confirming the hypothesis that ever better levels of [...]
IBA – ACQUISITION D’ACTIONS PROPRES
19/05/2025
Publication immédiate – 19 mai 2025 Louvain-la-Neuve, Belgique, 19 mai 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam [...]
IBA – ACQUISITION OF OWN SHARES
19/05/2025
Immediate Release – May 19 th , 2025 Louvain-la-Neuve, Belgium, May 19 th , 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam [...]
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
19/05/2025
EB Development franchit à la hausse le seuil de 90% Paris, le 19 mai 2024 - 17h40 - Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro et les sciences [...]
Eurobio Scientific: EB Development rises above 90% threshold
19/05/2025
EB Development rises above 90% threshold Paris, May 19, 2024 – 7:00 pm - Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life sciences, was informed [...]
Hospice Choices: VITAS® Healthcare Is Now Serving Marion County, Florida
19/05/2025
Florida’s most trusted hospice provider now reaches 59 of the state’s 67 counties OCALA, Fla., May 19, 2025 (GLOBE NEWSWIRE) -- Residents of North Central Florida now have easier access to high-quality, compassionate [...]
Transactions in Connection with Share Buy-back Program
19/05/2025
Company Announcement COPENHAGEN, Denmark; May 19, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital [...]
Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue
19/05/2025
HENDERSON, Nev., May 19, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: NIKA ) presents projected revenue for each market with exclusive distribution agreement. NIKA has previously reported an estimated [...]
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
19/05/2025
Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments ROSELAND, N.J., May 19, 2025 (GLOBE NEWSWIRE) -- Milestone [...]
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference
19/05/2025
Presentation to Focus on Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO) NESS ZIONA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American [...]
Healthcare Consulting & Contracting (HC3) Founder and Senior Toxicologist Dr. J. David Krause Honored with AIHA’s 2024 Lila Albin Best IEQ Paper Award
19/05/2025
Tallahassee, Florida , May 19, 2025 (GLOBE NEWSWIRE) -- Healthcare Consulting & Contracting (HC3), a leader in environmental health and toxicology consulting, proudly announces that its Founder and Senior [...]
BeeCure Celebrates World Bee Day
19/05/2025
Poinciana, Fl , May 19, 2025 (GLOBE NEWSWIRE) -- As World Bee Day approaches on May 20th, BeeCure© proudly joins the global community in honoring the vital role bees play in sustaining our planet. This day not only [...]
The Developing Doctor Launches New Online Course to Empower Early-Career Physicians
19/05/2025
New Online Course Helps Early-Career Physicians Navigate the Critical Transition from Training to Thriving Iowa City, Iowa , May 19, 2025 (GLOBE NEWSWIRE) -- The Developing Doctor, a leader in physician coaching and [...]
PhotoniCare's OtoSight Demonstrates More Accurate Diagnosis and a 50 Percent Reduction in Antibiotic Usage for Pediatric Ear Infections in Large Randomized Controlled Trial
19/05/2025
DURHAM, N.C. and GRAND RAPIDS, Mich., May 19, 2025 (GLOBE NEWSWIRE) -- PhotoniCare Inc., a medical device company dedicated to delivering innovation to frontline care that demonstrably enhances patient outcomes, is [...]
NovelMed’s Phase II Data in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Shows Best-in-Class Efficacy as Monotherapy
19/05/2025
--- Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH). Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) [...]
Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)
19/05/2025
GAITHERSBURG, Md., May 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, [...]
Atsena Therapeutics Announces Positive Clinical Data from Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy to Treat X-linked Retinoschisis (XLRS)
19/05/2025
First XLRS study to demonstrate efficacy and positive safety data in a Phase I/II trial Majority of patients demonstrated successful efficacy readouts across structural measurements (foveal schisis closure) and had [...]

Pages